An updated review of infliximab biosimilar, CT-P13, in the treatment of immune-mediated inflammatory diseases.

Immunotherapy
Seung Wook HongByong Duk Ye

Abstract

The introduction of anti-TNFs, such as infliximab (IFX), has revolutionized the treatment of immune-mediated inflammatory diseases. Anti-TNF agents have shown outstanding efficacy and long-term improvement of clinical outcomes, but the cost has been relatively high. Out of this concern, several 'biosimilar' drugs of anti-TNF agents have been developed. CT-P13, the first biosimilar of reference IFX, was approved by the European Medicines Agency and licensed by the US FDA for use in all indications of IFX. This updated review summarizes all aspects of CT-P13, including pharmacology and pharmacokinetics, and evaluates its efficacy, safety and immunogenicity for all indications based on the results of the latest clinical trials as well as on real-world experiences.

References

May 6, 1999·The New England Journal of Medicine·D H PresentS J van Deventer
Nov 30, 2000·The New England Journal of Medicine·P E LipskyUNKNOWN Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group
Jun 6, 2002·Lancet·Stephen B HanauerUNKNOWN ACCENT I Study Group
Feb 27, 2004·The New England Journal of Medicine·Bruce E SandsSander J van Deventer
Sep 25, 2004·Journal of the American Academy of Dermatology·Alice B GottliebAlan Menter
Jan 29, 2005·Annals of the Rheumatic Diseases·C AntoniUNKNOWN IMPACT 2 Trial Investigators
Feb 5, 2005·Arthritis and Rheumatism·Désirée van der HeijdeUNKNOWN Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group
Dec 13, 2005·The New England Journal of Medicine·Paul RutgeertsJean Frédéric Colombel
Mar 2, 2006·Arthritis and Rheumatism·Josef S SmolenUNKNOWN Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset (ASPIRE) S
Apr 4, 2007·Postgraduate Medical Journal·Annabel KuekAndrew J K Ostör
Aug 2, 2007·Expert Opinion on Biological Therapy·Herbert TilgArthur Kaser
Oct 25, 2012·Blood·Martina WeiseChristian K Schneider
Apr 12, 2014·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Kate McKeage
May 17, 2014·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Valentin BrodszkyMárta Péntek
Jun 26, 2014·Biologicals : Journal of the International Association of Biological Standardization·Brian G FeaganAnthony S Russell
Oct 10, 2014·Blood·Martina WeiseChristian K Schneider
Dec 18, 2014·MAbs·Soon Kwan JungShin Jae Chang
Sep 24, 2015·Expert Review of Gastroenterology & Hepatology·Sang Hyoung ParkSang Joon Lee
Sep 24, 2015·Expert Review of Gastroenterology & Hepatology·Jørgen JahnsenPetr Ricanek
Sep 24, 2015·Expert Review of Clinical Immunology·Ulf Müller-LadnerPeter Taylor
Feb 21, 2016·Journal of Crohn's & Colitis·Alon D LevinGijs R van den Brink
Mar 24, 2016·Scandinavian Journal of Gastroenterology·Radan KeilJulius Špičák
Oct 30, 2016·Journal of Crohn's & Colitis·Klaudia FarkasTamás Molnár
Oct 25, 2016·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Shomron Ben-HorinPeter Laszlo Lakatos
Dec 9, 2016·Journal of Crohn's & Colitis·Silvio DaneseLaurent Peyrin-Biroulet
Feb 2, 2017·Digestive Diseases·Zsuzsanna VeghPeter L Lakatos

❮ Previous
Next ❯

Methods Mentioned

BETA
glycosylation

Software Mentioned

IMID
PLANETRA
PLANETAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.